AA
MYOV

ALPS Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

ALPS Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-96,505
Closed -$1.28M – 1103
2022
Q1 		$1.28M Sell
96,505
-11,477
-11% -$154K 0.01% 284
2021
Q4 		$1.68M Buy
+107,982
New +$2.06M 0.02% 305
2017
Q2 		– Sell
-51,839
Closed -$600K – 792
2017
Q1 		$600K Sell
51,839
-4,400
-8% -$50.4K ﹤0.01% 281
2016
Q4 		$700K Buy
+56,239
New +$652K 0.01% 242

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ALPS Advisors's MYOV Position: Q2 2022 in Review

ALPS Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q2 2022, closing a stake of 96,505 shares — an estimated $1.28M sold.

ALPS Advisors first reported a position in MYOV in Q4 2016 and held it in 4 quarters. The position peaked at $1.68M in Q4 2021. 91 funds tracked by Wall St. Rank hold MYOV as of Q2 2022.

  • ALPS Advisors reported no remaining Myovant Sciences Ltd. position as of Q2 2022 after selling out during the quarter.
  • ALPS Advisors sold 96,505 Myovant Sciences Ltd. shares in Q2 2022, an estimated $1.28M.
  • ALPS Advisors first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 4 quarters.
  • ALPS Advisors's Myovant Sciences Ltd. position peaked at $1.68M in Q4 2021.
  • 91 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2022.

Based on ALPS Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.